Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4061303
Max Phase: Preclinical
Molecular Formula: C24H35ClN3NaO8S
Molecular Weight: 562.09
Molecule Type: Small molecule
Associated Items:
ID: ALA4061303
Max Phase: Preclinical
Molecular Formula: C24H35ClN3NaO8S
Molecular Weight: 562.09
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)C[C@@H]1NC(=O)OC(c2cccc(Cl)c2)CCCCCNC(=O)CC[C@@H](C(O)S(=O)(=O)[O-])NC1=O.[Na+]
Standard InChI: InChI=1S/C24H36ClN3O8S.Na/c1-15(2)13-19-22(30)27-18(23(31)37(33,34)35)10-11-21(29)26-12-5-3-4-9-20(36-24(32)28-19)16-7-6-8-17(25)14-16;/h6-8,14-15,18-20,23,31H,3-5,9-13H2,1-2H3,(H,26,29)(H,27,30)(H,28,32)(H,33,34,35);/q;+1/p-1/t18-,19-,20?,23?;/m0./s1
Standard InChI Key: IJNBFMZDMKUUJI-BZZQEFCISA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 562.09 | Molecular Weight (Monoisotopic): 561.1912 | AlogP: 2.68 | #Rotatable Bonds: 5 |
Polar Surface Area: 171.13 | Molecular Species: ACID | HBA: 7 | HBD: 5 |
#RO5 Violations: 1 | HBA (Lipinski): 11 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: -1.03 | CX Basic pKa: | CX LogP: 1.34 | CX LogD: 0.05 |
Aromatic Rings: 1 | Heavy Atoms: 37 | QED Weighted: 0.34 | Np Likeness Score: 0.46 |
1. Damalanka VC, Kim Y, Galasiti Kankanamalage AC, Lushington GH, Mehzabeen N, Battaile KP, Lovell S, Chang KO, Groutas WC.. (2017) Design, synthesis, and evaluation of a novel series of macrocyclic inhibitors of norovirus 3CL protease., 127 [PMID:28038326] [10.1016/j.ejmech.2016.12.033] |
Source(1):